Stem cells for pancreatic β-cell replacement in diabetes mellitus: Actual perspectives

Current Opinion in Organ Transplantation

Volumn 19, Issue 2, 2014, Pages 162-168

  Calafiore, Riccardo ^a   Montanucci, Pia ^a   Basta, Giuseppe ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

cell therapy; cure; insulin

Indexed keywords

ADIPOSE TISSUE; CELL LINEAGE; CELL REGENERATION; ENDOCRINE CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MESENCHYMAL STEM CELL; MOLECULAR THERAPY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; REVIEW; STEM CELL TRANSPLANTATION;

ADULT; ADULT STEM CELLS; CELL LINEAGE; CELL- AND TISSUE-BASED THERAPY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EMBRYONIC STEM CELLS; HUMANS; INSULIN-SECRETING CELLS; REGENERATION;

EID: 84897114479     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000055     Document Type: Review

References (68)

1. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010; 464:1293-1300.
2. Ashcroft FM, Rorsman P. Diabetes mellitus and the b cell: the last ten years. Cell 2012; 148:1160-1171.
3. Jensen RA, Agardh E, Lernmark A, et al. HLA genes, islet auto antibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later. PLoS One 2011; 6:e17569.
4. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012; 35:1436-1445.
5. McDonald E, Krishnamurthy M, Goodyer CG, Wang R. The emerging roles of SOX transcription factors in pancreatic endocrine cell development and function. Stem Cells Dev 2009; 18:1379-1387.
6. Puri S, Hebrok M. Cellular plasticity within the pancreas: lessons learned from development. Dev Cell 2010; 18:342-356.
7. Shao S, Fang Z, Yu X, Zhang M. Transcription factors involved in glucosestimulated insulin secretion of pancreatic beta cells. Biochem Biophys Res Commun 2009; 384:401-404.
8. Burlison JS, Long Q, Fujitani Y, et al. Pdx-1 and Ptf1a concurrently determine the fate specification of pancreatic multipotent progenitor cells. Dev Biol 2008; 316:74-86.
9. Kawaguchi Y, Cooper B, Gannon M, et al. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 2002; 32:128-134.
10. Sellick GS, Barker KT, Stolte-Dijkstra I, et al. Mutations in Ptf1a cause pancreatic and cerebellar agenesis. Nat Genet 2004; 36:1301-1305.
11. Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 2000; 97:1607-1611.
12. Sussel L, Kalamaras J, Hartingan-O'Connor DJ, et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998; 125:2213-2221.
13. Servitja JM, Ferrer J. Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia 2004; 47:597-613.
14. Desgraz R, Bonal C, Herrera PL. 126 b-cell regeneration: the pancreatic intrinsic faculty. Trends Endocrinol Metab 2011; 22:34-43.
15. Meier JJ, Butler AE, Saisho Y, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008; 57:1584-1594.
16. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429:41-46.
17. Willcox A, Richardson SJ, Bone AJ, et al. Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes. Diabetologia 2010; 53:2020-2028.
18. Keenan HA, Sun JK, Levine J, et al. Residual insulin production and pancreatic ?-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010; 59:2846-2853.
19. Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased betacell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-110.
20. Baeyens L, De Breuck S, Lardon J, et al. In vitro generation of insulinproducing beta cells from adult exocrine pancreatic cells. Diabetologia 2005; 48:49-57.
21. Baeyens L, Bouwens L. Can beta-cells be derived from exocrine pancreas? Diabetes Obes Metab 2008; 10:170-178.
22. Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008; 455:627-632.
23. Okuno M, Minami K, Okumachi A, et al. Generation of insulin-secreting cells from pancreatic acinar cells of animal models of type 1 diabetes. Am J Physiol Endocrinol Metab 2007; 292:e158-e165.
24. Bonner-Weir S, Taneja M, Weir GC, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 2000; 97:7999-8004.
25. Rosenberg L, Brown RA, Duguid WP. A new approach to the induction of duct epithelial hyperplasia and nesidioblastosis by cellophane wrapping of the hamster pancreas. J Surg Res 1983; 35:63-72.
26. Noguchi H, Xu G, Matsumoto S, et al. Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell Transplant 2006; 15:929-938.
27. Kopp JL, Dubois CL, Schaffer AE, et al. Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. Development 2011; 138:653-665.
28. Lysy PA, Weir GC, Bonner-Weir S. Concise review: pancreas regeneration -recent advances and perspectives. Stem Cells Transl Med 2012; 1:150-159.
29. Collombat P, Xu X, Ravassard P, et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 2009; 138:449-462.
30. Zhang D, Jiang W, Liu M, et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 2009; 19:429-438.
31. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormoneexpressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006; 24:1392-1401.
32. Thomson JA, Itskovitz-Eldor J, Shapiro S, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
33. Baldwin T. Morality and human embryo research. Introduction to the talking point on morality and human embryo research. EMBO Rep 2009; 10:299-300.
34. Soria B, Roche E, Berna G, et al. Insulin secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000; 49:157-162.
35. Sipione S, Eshpeter A, Lyon JG, et al. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 2004; 47:499-508.
36. Furth ME, Atala A. Stem cell sources to treat diabetes. J Cell Biochem 2009; 106:507-511.
37. Rolletscheck A, Kania G, Wobus AM. Generation of pancreatic insulinproducing cells from embryonic stem cells 'proof of principle', but questions still unanswered. Diabetologia 2006; 49:2541-2545.
38. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676.
39. Maehr R, Chen S, Snitow M, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A 2009; 106:15768-15773.
40. Laurent LC, Ulitsky I, Slavin I, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human eSCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011; 8:106-118.
41. Gutierrez-Aranda I, Ramos-Mejia V, Bueno C, et al. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 2010; 28:1568-1570.
42. Ricordi C, Inverardi L, Domínguez-Bendala J. From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes. Regen Med 2012; 7:41-48.
43. Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous non myeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297:1568-1576.
44. Snarski IE, Milczarczyk A, Torosian T, et al. Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I. Bone Marrow Transplant 2011; 46:562-566.
45. Mineo D, Ricordi C, Xu X, et al. Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant 2008; 8:1262-1274.
46. Wen Y, Chen B, Ildstad ST. Stem cell-based strategies for the treatment of type 1 diabetes mellitus. Expert Opin Biol Ther 2011; 11:41-53.
47. Ogawa M, Larue AC, Mehrotra M. Hematopoietic stem cells are pluripotent and not just 'hematopoietic'. Blood Cells Mol Dis 2013; 51:3-8.
48. Hung SC, Chen NJ, Hsieh SL, et al. Isolation and characterization of sizesieved stem cells from human bone marrow. Stem Cells 2002; 20:249-258.
49. Delorme B, Ringe J, Gallay N, et al. Specific plasma membrane protein phenotype of culture amplified and native human bone marrow mesenchymal stem cells. Blood 2008; 111:2631-2635.
50. Reger RL, Tucker AH, Wolfe MR. Differentiation and characterization of human MSCs. Methods Mol Biol 2008; 449:93-107.
51. Turnovcova K, Ruzickova K, Vanecek V, et al. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy 2009; 11:874-885.
52. Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006; 24:781-792.
53. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25:1384-1392.
54. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta cells. World J Gastroenterol 2004; 10:3016-3020.
55. Oh SH, Muzzonigro TM, Bae S, et al. Adult bone marrow-derived cells transdifferentiating into insulin-producing cells for treatment of type I diabetes. Lab Invest 2004; 84:607-617.
56. Wu XH, Liu CP, Xu KF, et al. Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol 2007; 13:3342-3349.
57. Moriscot C, De Fraipont F, Richard MJ, et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 2005; 23:594-604.
58. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13:4279-4295.
59. Schaffler A, Buchler C. Concise review: adipose tissue-derived stromal cellsbasic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25:818-827.
60. Kojima H, Fujimiya M, Matsumura K, et al. Extrapancreatic insulin-producing cells have been detected in the AT of diabetic mice. Proc Natl Acad Sci U S A 2004; 101:2458-2463.
61. Timper K, Seboek D, Eberhardt M, et al. Human adipose tissue derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006; 341:1135-1140.
62. Chandra VGS, Phadnis S, Nair PD, Bhonde RR. Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissuederived stem cells. Stem Cells 2009; 27:1941-1953.
63. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like from umbilical cord. Stem Cells 2003; 21:105-110.
64. La Rocca G, Anzalone R, Corrao S, et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 2009; 131:267-282.
65. Montanucci P, Basta G, Pescara T. New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly. Tissue Eng Part A 2011; 17:2651-2661.
66. Weiss ML, Anderson C, Medicetty S, et al. Immune properties of human umbilical cord Wharton's jelly-derived cells. StemCells 2008; 26:2865-2874.
67. Deuse T, Stubbendorff M, Tang-Quan K, et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 2011; 20:655-667.
68. Hu J, Yu X, Wang Z, et al. Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J 2013; 60:347-357.